Developmental Timeline: Detectable in rat striatal primordium by embryonic day 16 (E16), with peak expression in adulthood .
Brain Regions:
Peripheral Tissues: Transient expression during development .
| Behavior/Condition | GPR88⁻/− Phenotype |
|---|---|
| Motor coordination | Impaired rotarod performance |
| Anxiety-like behavior | Reduced marble burying, elevated open-arm time |
| Spatial learning | Enhanced Y-maze and cross-maze performance |
| Striatal dopamine | Increased D1/D2 receptor coupling |
Neurological Implications:
Modulates GABAergic/glutamatergic signaling and interacts with opioid/dopamine receptors .
Regulates emotional processing, motor control, and addiction pathways .
Agonists & Mechanisms:
RTI-13951-33:
(1R,2R)-2-PCCA: Binds allosteric pocket involving TM5/6 and Gαi1 subunit, enhancing Gi coupling .
Therapeutic Potential:
Alcohol Use Disorder: RTI-13951-33 normalizes striatal GPR88 activity without affecting water intake .
Parkinson’s Disease & Schizophrenia: Linked to dopaminergic dysregulation and cognitive deficits .
Key Reagents:
Catalog Cr1141-1: Recombinant rat GPR88 cell line (Multispan), validated in TR-FRET cAMP assays .
Antibodies & Protein: Available through AliCE® (AA 1-384, Strep Tag) for ELISA/Western blot .
Assay Systems:
Functional cAMP Assays: Measure forskolin-stimulated inhibition (EC₅₀ = 25–100 nM) .
Behavioral Models: Rotarod, elevated plus maze, and alcohol two-bottle choice paradigms .
GPR88 is an orphan G protein-coupled receptor (GPCR) consisting of 384 amino acids that forms a multi-pass membrane protein localizing to the cell membrane. It is expressed predominantly in the striatum, particularly in medium spiny neurons (MSNs) . Within the striatum, GPR88 shows high expression in both dopamine D1 receptor-expressing and D2 receptor-expressing MSNs .
Human GPR88 shares 95% sequence identity with its rat counterpart, indicating strong evolutionary conservation of this receptor . This high degree of sequence homology suggests that GPR88 likely performs critical and conserved functions across mammalian species. The strong conservation makes rat models particularly valuable for investigating GPR88 functions relevant to human physiology and pathology.
Several genetic models have been developed to study GPR88 function:
Total Gpr88 knockout mice (Gpr88-/-)
Conditional Gpr88 knockout using adenosine A2AR-Cre-driven recombination (A2AR-Gpr88 KO)
Cell-type specific knockout models
In Gpr88 knockout mice, medium spiny neurons display higher firing rates and increased sensitivity to cortical stimulation compared to wild-type controls . These models have revealed that GPR88 deletion leads to:
Increased locomotor activity
Hypersensitivity to novelty
Reduced anxiety-like behaviors
Impairments in rotarod performance and active-avoidance tasks
Conditional knockout models (like the A2AR-Gpr88 KO) have allowed researchers to study the contribution of GPR88 in specific neuronal populations, revealing distinct functions of GPR88 in different cell types .
GPR88 functions as a modulator of other GPCR signaling pathways. Studies have revealed that GPR88 can:
Inhibit the activation of both G protein- and β-arrestin-dependent signaling pathways of opioid receptors
Decrease G protein-dependent signaling of most receptors in close proximity
This buffering role appears to be selective, as GPR88 shows physical proximity with certain receptors but not others. Evidence indicates that GPR88 can form heteromeric complexes with:
Interestingly, no proximity was detected between GPR88 and dopamine D1 receptors, vasopressin V2 receptors, or chemokine CXCR4 receptors, suggesting selective interaction partners .
Based on published research, the following methodological approaches are recommended:
Proximity-based assays: BRET (Bioluminescence Resonance Energy Transfer) or FRET (Fluorescence Resonance Energy Transfer) to detect physical proximity between GPR88 and other GPCRs
Functional assays: G protein activation measurements (cAMP, calcium, MAPK) and β-arrestin recruitment assays in cells co-expressing GPR88 and partner receptors
Co-immunoprecipitation: To confirm physical interactions between GPR88 and other receptors
When conducting these experiments, researchers should:
Include appropriate positive and negative controls
Use both overexpression systems and native tissues
Compare signaling in wild-type versus Gpr88 knockout backgrounds
GPR88 plays a critical role in modulating anxiety-like behaviors, with distinct effects depending on the neuronal population expressing the receptor. Studies comparing total Gpr88 knockout mice with conditional A2AR-Gpr88 knockout mice have revealed:
| Behavioral Test | Total Gpr88 KO | A2AR-Gpr88 KO |
|---|---|---|
| Light/Dark Test | Decreased anxiety | Decreased anxiety |
| Elevated Plus Maze | Decreased anxiety | Decreased anxiety |
| Novelty Preference | Increased | No change |
| Novelty-Suppressed Feeding | Decreased | No change |
| Fear Conditioning | Decreased | No change |
These findings demonstrate that GPR88 expression in A2AR neurons (predominantly D2R-expressing MSNs) specifically enhances ethological anxiety-like behaviors without affecting conflict anxiety and fear responses . The anxiogenic activity of GPR88 therefore operates primarily at the level of A2AR-expressing neurons, while other GPR88-expressing neuronal populations likely mediate effects on approach behaviors and conditional fear .
GPR88 exerts a tonic inhibitory action on μ-opioid receptor (μOR) signaling. In Gpr88 knockout mice:
Morphine-induced locomotor sensitization is facilitated
Morphine withdrawal symptoms are enhanced
Supra-spinal analgesia is facilitated, as evidenced by increased jumping latency in the hot-plate test
Spinal analgesia (tail immersion test) is blunted
Extinction of morphine-induced conditioned place preference occurs more rapidly than in wild-type mice
These findings indicate that GPR88 normally constrains certain morphine-induced responses. Interestingly, while GPR88 deletion affects morphine responses, it does not alter morphine reward as measured by conditioned place preference acquisition and reinstatement .
GPR88 expression is necessary for efficient integration of effort and energy density information that guides instrumental choice during foraging . In wild-type animals, evolutionary pressure has favored neural systems that optimize energy efficiency by:
Detecting and comparing caloric value
Biasing foraging toward maximum energy efficiency
Guiding behavior toward superior nutritional density or minimized caloric expenditure
The striatum, where GPR88 is highly expressed, is anatomically and functionally positioned to perform the sensory and motor integration necessary for efficient action selection during foraging. GPR88 knockout mice show impaired ability to efficiently integrate effort and energy density information, suggesting that this receptor plays a critical role in these evolutionary conserved mechanisms .
Gene association studies in humans have revealed links between GPR88 function and several disorders:
The striatal enrichment of GPR88 and its role in modulating dopamine receptor signaling make it particularly relevant to disorders involving striatal dysfunction. The loss of GPR88's protective buffering role may contribute to neuropsychiatric conditions, as it normally dampens GPCR activity in striatal and amygdala neuronal populations .
GPR88 is considered a promising therapeutic target for neuropsychiatric disorders for several reasons:
Its selective expression pattern, predominantly in the striatum
Its ability to modulate multiple GPCR signaling pathways
Its involvement in anxiety-related behaviors, addiction processes, and motor functions
Potential therapeutic applications include:
Anxiety disorders: GPR88 antagonists might reduce anxiety-like behaviors based on knockout studies
Addiction: Modulating GPR88 might affect drug sensitization and withdrawal
Movement disorders: GPR88 modulation could potentially address disorders involving striatal dysfunction
The buffering role of GPR88 on striatal GPCR signaling suggests that pharmaceuticals targeting this receptor might help normalize dysregulated signaling in neuropsychiatric conditions .
For researchers working with recombinant rat GPR88:
Expression systems:
HEK293 cells for mammalian expression
Sf9 insect cells for higher yield
Stable cell lines expressing GPR88 with epitope tags (HA, FLAG, or His)
Purification approaches:
Storage conditions:
Conditional knockout studies have revealed distinct roles of GPR88 in different neuronal populations:
In A2AR-expressing neurons (predominantly D2R-MSNs):
In other neuronal populations:
Regulates approach behaviors and conditional fear
May contribute to reward processing and addiction-related behaviors
These findings highlight the importance of cell-type specific approaches when studying GPR88 function, as this receptor appears to play distinct roles depending on its cellular context .
For detection and quantification of GPR88, researchers should consider:
Antibody-based methods:
RNA-based methods:
qPCR for mRNA quantification
In situ hybridization for spatial localization
Recommended applications and dilutions:
| Application | Recommended Dilution |
|---|---|
| WB | 1:300-5000 |
| ELISA | 1:500-1000 |
| IHC-P | 1:200-400 |
| IHC-F | 1:100-500 |
| IF(IHC-P) | 1:50-200 |
| IF(IHC-F) | 1:50-200 |
| IF(ICC) | 1:50-200 |
| ICC | 1:100-500 |
These methodologies provide complementary approaches to study GPR88 expression at both protein and mRNA levels .